20/02/2004
Pilot scheme to target patients with inherited cancer risk
People who are deemed to have an increase cancer risk through inherited genetic disorders are set to benefit from a new £1.5 million testing, care and support programme.
A small proportion of breast, ovarian and bowel cancers are associated with particular inherited genes, and testing for these genes can identify whether someone with a strong family history of the disease is likely to develop it.
The Department of Health and Macmillian Cancer Relief are funding a programme of pilot projects which will identify patients at risk and provide them with appropriate advice, support and care.
The pilot scheme will run in south west London, north Kirklees, Bradford, south Durham, Teeside, north Yorkshire and south east London.
In each area GPs, cancer services will work together to ensure patients who are concerned about their family history of cancer are properly assessed and receive future care which is appropriate to their level of risk.
For many patients the outcome of their assessment will be simple reassurance and counselling that no further intervention is needed. For others it will involve genetic testing to more accurately gauge their level of risk and advice and support around prevention and treatment options.
Health Minister Lord Warner said: "By working closely with Macmillan Cancer Relief, service users and leading experts in cancer and genetics we will explore better ways of providing access to services for hereditary cancer to NHS patients who could benefit. The experiences and results of these pilots will be used to develop future cancer genetics services in England."
(gmcg)
A small proportion of breast, ovarian and bowel cancers are associated with particular inherited genes, and testing for these genes can identify whether someone with a strong family history of the disease is likely to develop it.
The Department of Health and Macmillian Cancer Relief are funding a programme of pilot projects which will identify patients at risk and provide them with appropriate advice, support and care.
The pilot scheme will run in south west London, north Kirklees, Bradford, south Durham, Teeside, north Yorkshire and south east London.
In each area GPs, cancer services will work together to ensure patients who are concerned about their family history of cancer are properly assessed and receive future care which is appropriate to their level of risk.
For many patients the outcome of their assessment will be simple reassurance and counselling that no further intervention is needed. For others it will involve genetic testing to more accurately gauge their level of risk and advice and support around prevention and treatment options.
Health Minister Lord Warner said: "By working closely with Macmillan Cancer Relief, service users and leading experts in cancer and genetics we will explore better ways of providing access to services for hereditary cancer to NHS patients who could benefit. The experiences and results of these pilots will be used to develop future cancer genetics services in England."
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
08 August 2011
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
12 January 2005
Cancer charity research reveals ignorance of cancer risk in UK
A large proportion of British people are ignorant about cancer risk factors, a survey conducted by a leading UK cancer charity has revealed. The report, commissioned by Cancer Research UK, shows that there is widespread confusion over what factors increase the risk of the disease, which is Britain's biggest killer.
Cancer charity research reveals ignorance of cancer risk in UK
A large proportion of British people are ignorant about cancer risk factors, a survey conducted by a leading UK cancer charity has revealed. The report, commissioned by Cancer Research UK, shows that there is widespread confusion over what factors increase the risk of the disease, which is Britain's biggest killer.
29 July 2010
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
£50M Fund For Cancer Drugs Announced
Cancer patients are set to get greater access to cancer drugs recommended by their doctors as a result of a new £50 million fund, the government has announced.
16 November 2005
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.